Medicine and Dentistry
Patient
100%
Inpatient
89%
COVID-19
84%
Chronic Obstructive Pulmonary Disease
78%
Hospital
74%
Evaluation Study
53%
COVID-19 Therapy
49%
Lung
29%
Epstein Barr Virus
29%
Valaciclovir
29%
Placebo
24%
Disease Exacerbation
24%
Sputum
24%
Amaurosis
22%
Epithelium
21%
Infection
20%
Virus
20%
Analysis
20%
Interstitial Lung Disease
19%
Pathogenesis
19%
Mortality
19%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Man
17%
Diseases
17%
Association
16%
Inflammation
15%
Age
14%
Bradykinin
14%
Therapeutic Procedure
14%
Randomized Controlled Trial
14%
Corticosteroid
13%
Viral Respiratory Tract Infection
13%
Pneumonia
12%
Receptor
12%
Death
12%
Morbidity
12%
Interferon
12%
Meta-Analysis
11%
Airflow
11%
Respiratory Tract Inflammation
11%
Health
11%
Tocilizumab
10%
Cytokine
10%
Coagulation
10%
Artificial Respiration
10%
Microbial Diversity
9%
Surgery
9%
Acetylsalicylic Acid
9%
Non Small Cell Lung Cancer
9%
Endothelium
9%
Immunology and Microbiology
Epstein Barr Virus
29%
Sputum
22%
Mortality
16%
Viral Disease
15%
Inflammation
12%
Human Rhinovirus
12%
Epithelium
11%
Reduction (Chemistry)
11%
Microbiome
9%
Cells
9%
Differentiation
9%
COVID-19
9%
Immunity
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Rhinovirus
9%
Lung
8%
Monospecific Antibody
7%
Virus
5%
Haemophilus influenzae
5%
Nursing and Health Professions
Hospital
29%
Evaluation Study
20%
Obstructive Lung Disease
19%
Combination Therapy
19%
Meta Analysis
11%
Valaciclovir
9%
Baricitinib
9%
Azithromycin
9%
Disease Exacerbation
9%
Quality of Life
7%
Rate Ratio
6%
Hospitalization
5%
Death
5%
Mortality
5%
